Initial presentations predict mortality in pulmonary tuberculosis patients - a prospective observational study

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Feng, Jia Yih ^a,b   Su, Wei Juin ^a,b   Chiu, Yu Chi ^a   Huang, Shiang Fen ^a   Lin, Yung Yang ^a,b   Huang, Ruay Ming ^c   Lin, Ching Hsiung ^d   Hwang, Jhi Jhu ^e   Lee, Jen Jyh ^f   Yu, Ming Chih ^g   Yu, Kwok Woon ^a   Lee, Yu Chin ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Hualien Hospital   (Taiwan)

^d CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f TZU CHI UNIVERSITY   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; AGE; AGED; ANOREXIA; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; DRUG EFFICACY; DYSPNEA; FEMALE; FEVER; FOLLOW UP; GENOTYPE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALAISE; MALE; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PREDICTION; PROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL TIME; TREATMENT RESPONSE; GENETICS; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM; PROGNOSIS; SURVIVAL RATE;

AGED; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TUBERCULOSIS, PULMONARY;

EID: 80052738117     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023715     Document Type: Article

References (28)

1. World Health Organization Global tuberculosis control-surveillance, planning, financing. (2008) Geneva. WHO/HTM/TB/ 2008.393.
2. Mugusi FM, Mehta S, Villamor E, Urassa W, Saathoff E, et al. (2009) Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis. BMC Public Health 12: 409.
3. Low S, Ang LW, Cutter J, James L, Chee CB, et al. (2009) Mortality among tuberculosis patients on treatment in Singapore. Int J Tuberc Lung Dis 13: 328-334.
4. Chiang CY, Lee JJ, Yu MC, Enarson DA, Lin TP, et al. (2009) Tuberculosis outcomes in Taipei: factors associated with treatment interruption for 2 months and death. Int J Tuberc Lung Dis 13: 105-111.
5. Sterling TR, Zhao Z, Khan A, Chaisson RE, Schluger N, et al. (2006) Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors. Int J Tuberc Lung Dis 10: 542-549.
6. Kim HJ, Lee CH, Shin S, Lee JH, Kim YW, et al. (2010) The impact of nutritional deficit on mortality of in-patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 14: 79-85.
7. Silva DR, Menegotto DM, Schulz LF, Gazzana MB, Dalcin Pde T, (2010) Factors associated with mortality in hospitalized patients with newly diagnosed tuberculosis. Lung 188: 33-41.
8. Rao VK, Iademarco EP, Fraser VJ, Kollef MH, (1998) The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest 114: 1244-1252.
9. Kourbatova EV, Borodulin BE, Borodulina EA, del Rio C, Blumberg HM, et al. (2006) Risk factors for mortality among adult patients with newly diagnosed tuberculosis in Samara, Russia. Int J Tuberc Lung Dis 10: 1224-1230.
10. Hoa NP, Thorson AE, (2006) Excess mortality and tuberculosis among individuals with prolonged cough: a population-based study from Vietnam. Int J Tuberc Lung Dis 10: 851-856.
11. Beadsworth MB, van Oosterhout JJ, Diver MJ, Faragher EB, Shenkin A, et al. (2008) Hypoadrenalism is not associated with early mortality during tuberculosis treatment in Malawi. Int J Tuberc Lung Dis 12: 314-318.
12. Su WJ, Huang CY, Huang CY, Perng RP, (2001) Utility of PCR assays for rapid diagnosis of BCG infection in children. Int J Tuberc Lung Dis 5: 380-384.
13. Nájera-Ortiz JC, Sánchez-Pérez HJ, Ochoa-Díaz H, Arana-Cedeño M, Lezama MS, et al. (2008) Demographic, health services and socio-economic factors associated with pulmonary tuberculosis mortality in Los Altos Region of Chiapas, Mexico. Int J Epidemiol 37: 786-795.
14. Harries AD, Hargreaves NJ, Kemp J, Jindani A, Enarson DA, et al. (2001) Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1. Lancet 357: 1519-1523.
15. Harries AD, Hargreaves NJ, Gausi F, Kwanjana JH, Salaniponi FM, (2001) High early death rate in tuberculosis patients in Malawi. Int J Tuberc Lung Dis 5: 1000-1005.
16. Tocque K, Convrey RP, Bellis MA, Beeching NJ, Davies PD, (2005) Elevated mortality following diagnosis with a treatable disease: tuberculosis. Int J Tuberc Lung Dis 9: 797-802.
17. Garin B, Glaziou P, Kassa-Kelembho E, Yassibanda S, Mbelesso P, et al. (1997) High mortality rates among patients with tuberculosis in Bangui, Central African Republic. Lancet 350: 1298.
18. Kliiman K, Altraja A, (2010) Predictors and mortality associated with treatment default in pulmonary tuberculosis. Int J Tuberc Lung Dis 14: 454-463.
19. Pablos-Méndez A, Sterling TR, Frieden TR, (1996) The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA 276: 1223-1228.
20. Liu YC, Lin HH, Chen YS, Su IJ, Huang TS, et al. (2010) Reduced health provider delay and tuberculosis mortality due to an improved hospital programme. Int J Tuberc Lung Dis 14: 72-78.
21. Kawai V, Soto G, Gilman RH, Bautista CT, Caviedes L, et al. (2006) Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru. Am J Trop Med Hyg 75: 1027-1033.
22. Yang CH, Feng CF, Tang CC, Chan PC, CDC Taiwan, (2009) Epidemiology of Human Immunodeficiency Virus Testing Among Tuberculosis Patients in Taiwan. Poster presentation at 2009 49th ICAAC, Abstract H-234.
23. European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis (2006) Beijing/W genotype Mycobacterium tuberculosis and drug resistance. Emerg Infect Dis 12: 736-743.
24. Feng JY, Su WJ, Liu LY, Tsai CC, Chang SC, (2009) Radiological presentation of pulmonary tuberculosis infected by the W-Beijing Mycobacterium tuberculosis strain. Int J Tuberc Lung Dis 13: 1387-1392.
25. Feng JY, Su WJ, Tsai CC, Chang SC, (2008) Clinical impact of Mycobacterium tuberculosis W-Beijing genotype strain infection on aged patients in Taiwan. J Clin Microbiol 46: 3127-3129.
26. Lan NTN, Lien HTK, Tung LB, Borgdorff MW, Kremer K, et al. (2003) Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam. Emerg Infect Dis 9: 1633-1635.
27. Zahar JR, Azoulay E, Klement E, De Lassence A, Lucet JC, et al. (2001) Delayed treatment contributes to mortality in ICU patients with severe active pulmonary tuberculosis and acute respiratory failure. Intensive Care Med 27: 513-520.
28. van Rie A, Warren R, Richardson M, Victor TC, Gie RP, et al. (1999) Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 341: 1174-1179.